Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 2

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
 30, 2025 
     10,071,286  
    $100,713  
     250  
    $2  
    $300,963,393  
    $-  
    $(290,398,663) 
    $10,665,445 

See accompanying notes to unaudited condensed consolidated financial statements.

3

OpGen, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(unaudited)

    Six Months Ended June 30,

    2025

    2024

    Cash flows from operating activities:

    Net income (loss) 
     
    $
    3,101,859

    $
    (1,288,382
    )
  
    Adjustments to reconcile net income (loss) to net
    cash used in operating activities:

    Depreciation and amortization

    92,959

    85,195

    Change in inventory reserve

    -

    (54,830
    )
  
    Stock compensation expense

    182,958

    556,628

    Loss on deconsolidation of subsidiaries

    -

    75,138

    Change in fair value of EIB loan guaranty

    -

    225,386

    Gain on impairment adjustment

    -

    (2,079,575
    )
  
    Changes in operating assets and liabilities:

    Accounts receivable

    (4,009,700
    )

    77,914

    Inventory

    -

    54,830

    Prepaid expenses and other current assets

    63,130

    (54,521
    )
  
    Deferred offering costs

    6,269

    -

    Intangible assets

    (12,500
    )

    -

    Accounts payable

    52,727

    17,220

    Accrued compensation and benefits

    (33,886
    )

    247,338

    Accrued liabilities

    (6,109
    )

    429,831

    Operating lease liabilities

    (83,044
    )

    (70,508
    )
  
    Deferred revenue

    -

    (25,926
    )
  
    Net cash used in operating activities

    (645,337
    )

    (1,804,262
    )

    Cash flows from investing activities